Table 4.
Product type | Animal | Disease prevention/targeted pathogens | Immunoglobulin type/origin | Administration (Oral/parenteral) |
---|---|---|---|---|
E. coli specific antibodies | Calves | Scour | Bovine colostrum IgG/IgY | Oral |
Antibacterial bovine serum antibodies | Cattle Calves Sheep |
Arcanobacterium pyogenes E. coli Mannheimia haemolytica Pasteurella multocida Salmonella Typhimurium |
Bovine serum | Parenteral |
Clostridial antitoxins | Cattle Calves Goat Sheep Swine Horses |
Clostridium perfringens C&D Clostridium Botulinium C&B |
Equine Ig | Parenteral (sc and iv) |
Tetanus Antitoxin | Horses Cattle Sheep Swine Goats |
Tetanus | Equine serum | Parenteral |
Anti-West Nile Virus Antibodies | Horses | West Nile Virus | Equine Ig | Parenteral |
Anti-endotoxin antibodies | Horses | Septicaemia | Equine plasma from hyper-immune horses | Parenteral |
Antibacterial plasma antibodies | Horses |
Rhodococcus equi E. coli J-5 |
Equine plasma from hyper-immune horses | Parenteral |
Equine plasma | Horses | Failure of Passive Transfer | Equine plasma | Both |